198 related articles for article (PubMed ID: 23597914)
1. Immunolocalization of heparin-binding EGF-like growth factor (HB-EGF) as a possible immunotarget in diagnosis of some soft tissue sarcomas.
Musumeci G; Travali S; Di Rosa M; Scuderi R; Failla A; Imbesi R; Castrogiovanni P
Acta Histochem; 2013 Sep; 115(7):719-27. PubMed ID: 23597914
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal analysis and the classification of soft tissue sarcomas.
Molenaar WM; DeJong B; Buist J; Idenburg VJ; Seruca R; Vos AM; Hoekstra HJ
Lab Invest; 1989 Feb; 60(2):266-74. PubMed ID: 2536862
[TBL] [Abstract][Full Text] [Related]
3. Heterologous and rare homologous sarcomas of the uterine corpus: a clinicopathologic review.
Fadare O
Adv Anat Pathol; 2011 Jan; 18(1):60-74. PubMed ID: 21169739
[TBL] [Abstract][Full Text] [Related]
4. Clear cell tumors of the somatic soft tissues.
d'Amore ES; Ninfo V
Semin Diagn Pathol; 1997 Nov; 14(4):270-80. PubMed ID: 9383826
[TBL] [Abstract][Full Text] [Related]
5. Mammalian target of rapamycin pathway activity in alveolar soft part sarcoma.
Reis H; Hager T; Wohlschlaeger J; Bauer S; Katenkamp K; Katenkamp D; Baba HA
Hum Pathol; 2013 Oct; 44(10):2266-74. PubMed ID: 23871289
[TBL] [Abstract][Full Text] [Related]
6. Histopathological re-classification of extremity pleomorphic soft tissue sarcoma has clinical relevance.
Massi D; Beltrami G; Capanna R; Franchi A
Eur J Surg Oncol; 2004 Dec; 30(10):1131-6. PubMed ID: 15522563
[TBL] [Abstract][Full Text] [Related]
7. The comparative role of immunohistochemistry and electron microscopy in the identification of myogenic differentiation in soft tissue pleomorphic sarcomas.
Franchi A; Massi D; Santucci M
Ultrastruct Pathol; 2005; 29(3-4):295-304. PubMed ID: 16036884
[TBL] [Abstract][Full Text] [Related]
8. Membrane type 1-matrix metalloproteinase cleaves off the NH2-terminal portion of heparin-binding epidermal growth factor and converts it into a heparin-independent growth factor.
Koshikawa N; Mizushima H; Minegishi T; Iwamoto R; Mekada E; Seiki M
Cancer Res; 2010 Jul; 70(14):6093-103. PubMed ID: 20587521
[TBL] [Abstract][Full Text] [Related]
9. Anti-CD10 (56C6) expression in soft tissue sarcomas.
Deniz K; Çoban G; Okten T
Pathol Res Pract; 2012 May; 208(5):281-5. PubMed ID: 22464152
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP Study Group. Chromosomes and MorPhology.
Mertens F; Fletcher CD; Dal Cin P; De Wever I; Mandahl N; Mitelman F; Rosai J; Rydholm A; Sciot R; Tallini G; Van den Berghe H; Vanni R; Willén H
Genes Chromosomes Cancer; 1998 May; 22(1):16-25. PubMed ID: 9591630
[TBL] [Abstract][Full Text] [Related]
11. High-level expression of podoplanin in benign and malignant soft tissue tumors: immunohistochemical and quantitative real-time RT-PCR analysis.
Xu Y; Ogose A; Kawashima H; Hotta T; Ariizumi T; Li G; Umezu H; Endo N
Oncol Rep; 2011 Mar; 25(3):599-607. PubMed ID: 21234520
[TBL] [Abstract][Full Text] [Related]
12. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
[TBL] [Abstract][Full Text] [Related]
13. A three-gene signature for outcome in soft tissue sarcoma.
Hoffmann AC; Danenberg KD; Taubert H; Danenberg PV; Wuerl P
Clin Cancer Res; 2009 Aug; 15(16):5191-8. PubMed ID: 19671876
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of soft tissue sarcomas.
Enjoji M; Hashimoto H
Pathol Res Pract; 1984 Jan; 178(3):215-26. PubMed ID: 6326068
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-7 activates heparin-binding epidermal growth factor-like growth factor in cutaneous squamous cell carcinoma.
Kivisaari AK; Kallajoki M; Ala-aho R; McGrath JA; Bauer JW; Königová R; Medvecz M; Beckert W; Grénman R; Kähäri VM
Br J Dermatol; 2010 Oct; 163(4):726-35. PubMed ID: 20586780
[TBL] [Abstract][Full Text] [Related]
16. Differentiating soft tissue leiomyosarcoma and undifferentiated pleomorphic sarcoma: A miRNA analysis.
Guled M; Pazzaglia L; Borze I; Mosakhani N; Novello C; Benassi MS; Knuutila S
Genes Chromosomes Cancer; 2014 Aug; 53(8):693-702. PubMed ID: 24771630
[TBL] [Abstract][Full Text] [Related]
17. Paracrine activity of heparin-binding EGF-like growth factor in atherogenesis: an immunohistochemical study.
Castrogiovanni P; Scuderi R; Travali S; Failla A; Failla G; Imbesi R
Minerva Med; 2013 Feb; 104(1):85-91. PubMed ID: 23392541
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of heparin-binding epidermal growth factor-like growth factor as a newly identified pathogenic mechanism of antiphospholipid-mediated defective placentation.
Di Simone N; Marana R; Castellani R; Di Nicuolo F; D'Alessio MC; Raschi E; Borghi MO; Chen PP; Sanguinetti M; Caruso A; Meroni PL
Arthritis Rheum; 2010 May; 62(5):1504-12. PubMed ID: 20131286
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of bone morphogenetic proteins in bone and soft-tissue sarcomas.
Yoshikawa H; Rettig WJ; Lane JM; Takaoka K; Alderman E; Rup B; Rosen V; Healey JH; Huvos AG; Garin-Chesa P
Cancer; 1994 Aug; 74(3):842-7. PubMed ID: 8039112
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence in situ hybridization in the diagnosis of soft tissue neoplasms: a review.
Tanas MR; Goldblum JR
Adv Anat Pathol; 2009 Nov; 16(6):383-91. PubMed ID: 19851129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
